Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021 2022-01-06
CONNECTED TRANSACTION ANNOUNCEMENT - RENEWAL OF THE LEASE AGREEMENT 2022-01-03
Next Day Disclosure Return 2021-12-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021 2021-12-03
Next Day Disclosure Return 2021-11-26
GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME 2021-11-25
VOLUNTARY ANNOUNCEMENT - KN035 (ENVAFOLIMAB) OBTAINED MARKETING APPROVAL IN CHINA FROM NMPA 2021-11-25
VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY NMPA FOR A PHASE III CLINICAL TRIAL OF KN046 FOR THE TREATMENT OF ADVANCED PDAC 2021-11-23
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021 2021-11-04
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF COMMERCIAL OFFICER 2021-11-02

14 15 16 17 18 19 20